NEW YORK, Jan. 08, 2024 (GLOBE NEWSWIRE) -- Anavex Life Sciences Corp. (œAnavex or the œCompany) (Nasdaq: AVXL), a clinical-stage biopharmaceutical company developing differentiated therapeutics...
Anavex’s experimental drug fails Rett syndrome study, stock falls
NEW YORK, Dec. 19, 2023 (GLOBE NEWSWIRE) -- Anavex Life Sciences Corp. (œAnavex or the œCompany) (Nasdaq: AVXL), a clinical-stage biopharmaceutical company developing differentiated therapeutics...
NEW YORK, Nov. 22, 2023 (GLOBE NEWSWIRE) -- Anavex Life Sciences Corp. (œAnavex or the œCompany) (Nasdaq: AVXL), a clinical-stage biopharmaceutical company developing differentiated therapeutics...
NEW YORK, Nov. 20, 2023 (GLOBE NEWSWIRE) -- Anavex Life Sciences Corp. (“Anavex” or the “Company”) (Nasdaq: AVXL), a clinical-stage biopharmaceutical company developing differentiated therapeutics...
NEW YORK, Sept. 14, 2023 (GLOBE NEWSWIRE) -- Anavex Life Sciences Corp. (œAnavex or the œCompany) (Nasdaq: AVXL), a clinical-stage biopharmaceutical company developing differentiated therapeutics...
NEW YORK, June 28, 2023 (GLOBE NEWSWIRE) -- Anavex Life Sciences Corp. (œAnavex or the œCompany) (Nasdaq: AVXL), a clinical-stage biopharmaceutical company developing differentiated therapeutics...
NEW YORK, June 06, 2023 (GLOBE NEWSWIRE) -- Anavex Life Sciences Corp. (œAnavex or the œCompany) (Nasdaq: AVXL), a clinical-stage biopharmaceutical company developing differentiated therapeutics...
NEW YORK, June 01, 2023 (GLOBE NEWSWIRE) -- Anavex Life Sciences Corp. (œAnavex or the œCompany) (Nasdaq: AVXL), a clinical-stage biopharmaceutical company developing differentiated therapeutics...
NEW YORK, May 01, 2023 (GLOBE NEWSWIRE) -- Anavex Life Sciences Corp. (“Anavex” or the “Company”) (Nasdaq: AVXL), a clinical-stage biopharmaceutical company developing differentiated therapeutics...